The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

Organic growth of 5% and record orders exceeding $1 billion were driven by intentional portfolio pivots toward data centers, semiconductor, and space and defense markets.

The Health & Science Technologies (HST) segment led performance with 47% organic order growth, fueled by rapid data center build-outs and liquid cooling infrastructure needs.

Management attributed margin expansion to strong volume leverage and the application of 8020 principles, particularly within newly acquired high-growth businesses.

The semiconductor portfolio has shifted toward a more resilient model, with approximately 50% of revenues now being recurring following the Mott acquisition.

In the Fluid & Metering Technologies (FMT) segment, double-digit growth in the water platform was driven by municipal wastewater analytics and high-purity semiconductor fabrication solutions.

Management noted a shift in demand patterns where large OEM commitments for 2027 are providing unusual long-term visibility compared to traditional rapid-replenishment cycles.

Full-year 2026 organic growth guidance was raised to 5-6%, reflecting a strong order book in HST and emerging signs of improvement in industrial end markets.

Capital expenditure forecast increased to $110 million to support capacity expansions for high-return businesses with visibility into 2027 and 2028 demand.

Management expects healthy volume leverage to continue through the second half of 2026, particularly within the HST segment's advantaged markets.

The 2026 outlook assumes low double-digit growth for HST, while FMT and FSDP are expected to be slightly up year-over-year as short-cycle demand stabilizes.

Strategic focus remains on 'moving laterally' with existing technologies to exploit new commercial opportunities in high-purity gas filtration and optical detection.

IEEPA-related tariff refunds provided a net $0.08 benefit to adjusted EPS, primarily through reduced cost of sales and interest income.

Organic growth was negatively impacted by 2% in the quarter due to expected customer rebates associated with the tariff refunds.

Management highlighted potential uncertainty in broad industrial markets related to geopolitical tensions, interest rate directions, and persistent inflation.

A large dollar optical systems program transition is creating a temporary offset within the life sciences portfolio as it moves between platforms.

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.

Management observed that while large OEM orders led the quarter, typical 'up and down the street' distribution orders showed sequential improvement in June and July.

The recovery is currently bifurcated between long-lead secular drivers and traditional rapid-replenishment channels, with both now showing positive momentum.

IDEX currently has twice the business set up for the following year compared to the same period last year, specifically in data center and space sectors.

While visibility has improved, management cautioned that the vast majority of the company still operates on a rapid-replenishment model with short lead times.

The platform's success is driven by being the 'tip of the spear' in diagnostics, providing low-cost, high-impact analytics for aging municipal infrastructure.

Growth is further bolstered by high-purity water solutions for semiconductor fabs that offer significant environmental sustainability benefits over competitors.

Management is actively cultivating proprietary M&A opportunities to fill technology gaps in the current growth platforms.

Share repurchases are planned at a $75 million quarterly pace but remain flexible based on the M&A pipeline and leverage levels.